Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2018

14.03.2018 | Original article

Visit-to-visit blood pressure variability in children and adolescents with renal disease

verfasst von: Hisayo Fujita, Seiji Matsuoka, Midori Awazu

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Increase in blood pressure (BP) variability (BPV) is associated with cardiovascular events, target organ damage, and arterial stiffness in adults. We previously reported that 24-h BPV may be associated with arterial stiffness and underlie white-coat hypertension (WCH). In this study, we examined whether visit-to-visit variability (VVV) could predict WCH and whether VVV correlated with eGFR, eGFR slope, and albuminuria/proteinuria in children and adolescents with renal diseases.

Methods

VVV was determined as average real variability of office BP measurements between visits, and 24-h BPV as the standard deviation of 24-h ambulatory BP. In 35 renal patients (25 boys and 10 girls, 7–18 years of age), divided into normotension (NT), WCH, and hypertension (HTN), the relationships between VVV and 24-h BPV and VVV in each BP category were studied. In separate 48 renal patients (24 boys and 24 girls, 2–18 years of age), the correlation between VVV and eGFR, eGFR slope, urine albumin or protein excretion was examined.

Results

Systolic VVV was significantly correlated with systolic office BP index. There was no correlation between VVV and 24-h BPV or 24-h pulse pressure. In addition, VVV was not different among NT, WCH, and HTN. Systolic VVV was significantly negatively correlated with eGFR but not with eGFR slope, albuminuria, or proteinuria. A cut-off value of systolic VVV for detecting eGFR < 60 ml/min per 1.73 m2 was 8.5.

Conclusion

VVV could not predict WCH. Systolic VVV correlated with eGFR but not with eGFR slope, albuminuria/proteinuria. Increased VVV could be a marker of decreased eGFR.
Literatur
1.
Zurück zum Zitat Fujita H, Matsuoka S, Awazu M. White-coat and reverse white-coat effects correlate with 24-h pulse pressure and systolic blood pressure variability in children and young adults. Pediatr Cardiol. 2016;37:345–52.CrossRefPubMed Fujita H, Matsuoka S, Awazu M. White-coat and reverse white-coat effects correlate with 24-h pulse pressure and systolic blood pressure variability in children and young adults. Pediatr Cardiol. 2016;37:345–52.CrossRefPubMed
2.
Zurück zum Zitat Masugata H, Senda S, Murao K, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res. 2011;34:846–50.CrossRefPubMed Masugata H, Senda S, Murao K, et al. Visit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patients. Hypertens Res. 2011;34:846–50.CrossRefPubMed
3.
Zurück zum Zitat Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care. 2010;33:2442–7.CrossRefPubMedPubMedCentral Kilpatrick ES, Rigby AS, Atkin SL. The role of blood pressure variability in the development of nephropathy in type 1 diabetes. Diabetes Care. 2010;33:2442–7.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res. 2013;36:151–7.CrossRefPubMed Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res. 2013;36:151–7.CrossRefPubMed
5.
Zurück zum Zitat Brickman AM, Reitz C, Luchsinger JA, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67:564–9.CrossRefPubMedPubMedCentral Brickman AM, Reitz C, Luchsinger JA, et al. Long-term blood pressure fluctuation and cerebrovascular disease in an elderly cohort. Arch Neurol. 2010;67:564–9.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tedla YG, Yano Y, Carnethon M, et al. Association between long-term blood pressure variability and 10-Year progression in arterial stiffness: the multiethnic study of atherosclerosis. Hypertension. 2017;69:118–27.CrossRefPubMed Tedla YG, Yano Y, Carnethon M, et al. Association between long-term blood pressure variability and 10-Year progression in arterial stiffness: the multiethnic study of atherosclerosis. Hypertension. 2017;69:118–27.CrossRefPubMed
7.
Zurück zum Zitat Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.CrossRefPubMed Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375:895–905.CrossRefPubMed
8.
Zurück zum Zitat Wang J, Shi X, Ma C, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017;35:10–7.CrossRefPubMed Wang J, Shi X, Ma C, et al. Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2017;35:10–7.CrossRefPubMed
9.
Zurück zum Zitat Diaz KM, Tanner RM, Falzon L, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965–82.CrossRefPubMed Diaz KM, Tanner RM, Falzon L, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension. 2014;64:965–82.CrossRefPubMed
10.
Zurück zum Zitat Chen W, Srinivasan SR, Ruan L, et al. Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the Bogalusa Heart Study. Am J Hypertens. 2011;24:77–82.CrossRefPubMed Chen W, Srinivasan SR, Ruan L, et al. Adult hypertension is associated with blood pressure variability in childhood in blacks and whites: the Bogalusa Heart Study. Am J Hypertens. 2011;24:77–82.CrossRefPubMed
11.
Zurück zum Zitat Yano Y, Ning H, Allen N, et al. Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension. 2014;64:983–8.CrossRefPubMed Yano Y, Ning H, Allen N, et al. Long-term blood pressure variability throughout young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hypertension. 2014;64:983–8.CrossRefPubMed
12.
Zurück zum Zitat Lande MB, Mendley SR, Matheson MB, et al. Association of blood pressure variability and neurocognition in children with chronic kidney disease. Pediatr Nephrol. 2016;31:2137–44.CrossRefPubMedPubMedCentral Lande MB, Mendley SR, Matheson MB, et al. Association of blood pressure variability and neurocognition in children with chronic kidney disease. Pediatr Nephrol. 2016;31:2137–44.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Sethna CB, Meyers KEC, Mariani LH, et al. Blood pressure and visit-to-visit blood pressure variability among individuals with primary proteinuric glomerulopathies novelty and significance. Hypertension. 2017;70:315–23.CrossRefPubMed Sethna CB, Meyers KEC, Mariani LH, et al. Blood pressure and visit-to-visit blood pressure variability among individuals with primary proteinuric glomerulopathies novelty and significance. Hypertension. 2017;70:315–23.CrossRefPubMed
14.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.CrossRef
15.
Zurück zum Zitat Imai Y, Sasaki S, Minami N, et al. The accuracy and performance of the A&D TM 2421,a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens. 1992;5:719–26.CrossRefPubMed Imai Y, Sasaki S, Minami N, et al. The accuracy and performance of the A&D TM 2421,a new ambulatory blood pressure monitoring device based on the cuff-oscillometric method and the Korotkoff sound technique. Am J Hypertens. 1992;5:719–26.CrossRefPubMed
16.
Zurück zum Zitat O’Sullivan JJ, Derrick G, Griggs PE, et al. Validation of the Takeda 2421 ambulatory blood pressure monitor in children. J Med Eng Technol. 1998;22:101–5.CrossRefPubMed O’Sullivan JJ, Derrick G, Griggs PE, et al. Validation of the Takeda 2421 ambulatory blood pressure monitor in children. J Med Eng Technol. 1998;22:101–5.CrossRefPubMed
17.
Zurück zum Zitat Wühl E, Witte K, Soergel M, et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20:1995–2007.CrossRefPubMed Wühl E, Witte K, Soergel M, et al. Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role of body dimensions. J Hypertens. 2002;20:1995–2007.CrossRefPubMed
19.
Zurück zum Zitat Sorof JM, Poffenbarger T, Franco K, et al. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14:855–60.CrossRefPubMed Sorof JM, Poffenbarger T, Franco K, et al. Evaluation of white coat hypertension in children: importance of the definitions of normal ambulatory blood pressure and the severity of casual hypertension. Am J Hypertens. 2001;14:855–60.CrossRefPubMed
20.
Zurück zum Zitat Levitan EB, Kaciroti N, Oparil S, et al. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens. 2013;27:589–93.CrossRefPubMed Levitan EB, Kaciroti N, Oparil S, et al. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens. 2013;27:589–93.CrossRefPubMed
21.
Zurück zum Zitat Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626–33.CrossRefPubMed Uemura O, Nagai T, Ishikura K, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626–33.CrossRefPubMed
22.
Zurück zum Zitat Yano Y. Visit-to-visit blood pressure variability-what is the current challenge? Am J Hypertens. 2017;30:112–4.CrossRefPubMed Yano Y. Visit-to-visit blood pressure variability-what is the current challenge? Am J Hypertens. 2017;30:112–4.CrossRefPubMed
23.
Zurück zum Zitat Muntner P, Shimbo D, Diaz KM, et al. Low correlation between visit-to-visit variability and 24-h variability of blood pressure. Hypertens Res. 2013;36:940–6.CrossRefPubMed Muntner P, Shimbo D, Diaz KM, et al. Low correlation between visit-to-visit variability and 24-h variability of blood pressure. Hypertens Res. 2013;36:940–6.CrossRefPubMed
24.
Zurück zum Zitat Parati G, Ochoa JE, Lombardi C, et al. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143–55.CrossRefPubMed Parati G, Ochoa JE, Lombardi C, et al. Assessment and management of blood-pressure variability. Nat Rev Cardiol. 2013;10:143–55.CrossRefPubMed
25.
Zurück zum Zitat Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011;29:2332–8.CrossRefPubMedPubMedCentral Muntner P, Joyce C, Levitan EB, et al. Reproducibility of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens. 2011;29:2332–8.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Kang IS, Pyun WB, Shin J, et al. Higher blood pressure variability in white coat hypertension; from the Korean ambulatory blood pressure monitoring registry. Korean Circ J. 2016;46:365–73.CrossRefPubMedPubMedCentral Kang IS, Pyun WB, Shin J, et al. Higher blood pressure variability in white coat hypertension; from the Korean ambulatory blood pressure monitoring registry. Korean Circ J. 2016;46:365–73.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Gijon-Conde T, Graciani A, Lopez-Garcia E, et al. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain. Hypertens Res. 2017;40:613–9.CrossRefPubMed Gijon-Conde T, Graciani A, Lopez-Garcia E, et al. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain. Hypertens Res. 2017;40:613–9.CrossRefPubMed
28.
Zurück zum Zitat Hussein WF, Chang TI. Visit-to-visit variability of systolic blood pressure and cardiovascular disease. Curr Hypertens Rep. 2015;17:14.CrossRefPubMed Hussein WF, Chang TI. Visit-to-visit variability of systolic blood pressure and cardiovascular disease. Curr Hypertens Rep. 2015;17:14.CrossRefPubMed
29.
Zurück zum Zitat Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160–6.CrossRefPubMed Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension. 2011;57:160–6.CrossRefPubMed
30.
Zurück zum Zitat Diaz KM, Feairheller DL, Sturgeon KM, et al. Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function. Int J Hypertens. 2011;2010:137206.PubMedPubMedCentral Diaz KM, Feairheller DL, Sturgeon KM, et al. Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function. Int J Hypertens. 2011;2010:137206.PubMedPubMedCentral
31.
Zurück zum Zitat Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res. 2012;35:239–43.CrossRefPubMed Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res. 2012;35:239–43.CrossRefPubMed
32.
Zurück zum Zitat Parati G, Liu X, Ochoa JE. Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens. 2014;28:403–9.CrossRefPubMed Parati G, Liu X, Ochoa JE. Clinical relevance of visit-to-visit blood pressure variability: impact on renal outcomes. J Hum Hypertens. 2014;28:403–9.CrossRefPubMed
33.
Zurück zum Zitat Yano Y, Fujimoto S, Kramer H, et al. Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.CrossRefPubMed Yano Y, Fujimoto S, Kramer H, et al. Long-term blood pressure variability, new-onset diabetes mellitus, and new-onset chronic kidney disease in the Japanese general population. Hypertension. 2015;66:30–6.CrossRefPubMed
34.
Zurück zum Zitat McMullan CJ, Lambers Heerspink HJ, Parving HH, et al. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis. 2014;64:714–22.CrossRefPubMed McMullan CJ, Lambers Heerspink HJ, Parving HH, et al. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial. Am J Kidney Dis. 2014;64:714–22.CrossRefPubMed
35.
Zurück zum Zitat McMullan CJ, Bakris GL, Phillips RA, et al. Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol. 2013;8:731–8.CrossRefPubMedPubMedCentral McMullan CJ, Bakris GL, Phillips RA, et al. Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol. 2013;8:731–8.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Nakano C, Morimoto S, Nakahigashi M, et al. The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease. Hypertens Res. 2015;38:193–8.CrossRefPubMed Nakano C, Morimoto S, Nakahigashi M, et al. The relationships between visit-to-visit blood pressure variability and renal and endothelial function in chronic kidney disease. Hypertens Res. 2015;38:193–8.CrossRefPubMed
37.
Zurück zum Zitat Lasserson DS, Scherpbier de Haan N, de Grauw W, et al. What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data. BMJ Open. 2016;6:e010702.CrossRefPubMedPubMedCentral Lasserson DS, Scherpbier de Haan N, de Grauw W, et al. What is the relationship between renal function and visit-to-visit blood pressure variability in primary care? Retrospective cohort study from routinely collected healthcare data. BMJ Open. 2016;6:e010702.CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Whelton PK, Pollock BD. Is it time to employ a measure of visit-to-visit variability in clinical practice? Hypertension. 2017;70:227–8.CrossRefPubMed Whelton PK, Pollock BD. Is it time to employ a measure of visit-to-visit variability in clinical practice? Hypertension. 2017;70:227–8.CrossRefPubMed
39.
Zurück zum Zitat Kollias A, Stergiou GS, Kyriakoulis KG, et al. Treating visit-to-visit blood pressure variability to improve prognosis: is amlodipine the drug of choice? Hypertension. 2017;70:862–6.CrossRefPubMed Kollias A, Stergiou GS, Kyriakoulis KG, et al. Treating visit-to-visit blood pressure variability to improve prognosis: is amlodipine the drug of choice? Hypertension. 2017;70:862–6.CrossRefPubMed
Metadaten
Titel
Visit-to-visit blood pressure variability in children and adolescents with renal disease
verfasst von
Hisayo Fujita
Seiji Matsuoka
Midori Awazu
Publikationsdatum
14.03.2018
Verlag
Springer Singapore
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2018
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1557-3

Weitere Artikel der Ausgabe 5/2018

Clinical and Experimental Nephrology 5/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.